in Precision Health
Our approach is rooted in a new paradigm – evolving from reactive healthcare to predictive, preventive and personalized healthcare by leveraging big data, better lifestyles, tailored diet, and breakthrough treatments, as each individual’s health experience and longevity potential are unique.
We invest in companies with disruptive technologies, based on strong intellectual property, that can improve people’s longevity and quality of life, stemming from three distinct but overlapping areas: Biotechnology, Advanced Nutrition and Digital Health.
The best science
the future of food.
A strong enabler
of “Personalized health”.
sensitivities by mapping protein
interactions with our body.”
experience is unique and
deserves personalized care.”
to a billion people. ”
for everyone while being good
to animals and the planet. ”
The founders of Precision Health Corp. are international executives and thought
leaders with deep banking, investment, and science expertise.
Founding investor and directorStefan’s career spans the academic, corporate and entrepreneurial sectors. Former CTO and Executive Board member of Nestlé Global, he also served as Head of Neuroscience at the Glaxo Institute, as Chairman of Cell Biology at the School of Medicine of Lausanne, and as Vice-President Research at the Swiss Ecole Polytechnique Fédérale. He cofounded and advised biotechnology companies and large investment funds.
Ukko Co-Founder and CEO
PHC Co-Founder and Director
Go Forward Co-Founder and CEO
for everyone while being good to animals and the planet. ”
Aleph Farms Co-Founder and CEO
Founding investorJean-Pierre has more than twenty years’ experience in private banking and wealth management. Prior to co-Founding Crossbridge Capital, he was a Director at Credit Suisse, where he was a core member of a three-person team credited with building a significant wealth management portfolio, representing a major portion of the Middle East activity of the London office. Prior to joining Credit Suisse, Jean-Pierre was an Analyst at JP Morgan Private Bank.
How we invest
Early and late-stage private companies represent more than 80% of our assets.
We also consider crossover rounds, IPOs, listed companies and selected funds that have a specific thematic or geographical advantage and give us co-investment rights.
Board of Directors
Precision Health Corp. is a protected cell company that is registered in the Isle of Man, a jurisdiction
which offers mature financial services with experienced, professional, legal and accounting infrastructure.
The regulatory environment is thorough and pragmatic with a tax-neutral environment for companies.
Our portfolio in the three investment areas:
Biotechnology, Advanced Nutrition and Digital Health.
Please get in touch using our form. Your message will be dispatched
directly to us and we will answer you as soon as we can.